4.7 Article

Trajectories of self-reported sleep disturbance across inpatient psychiatric treatment predict clinical outcome in comorbid major depressive disorder and generalized anxiety disorder

Journal

JOURNAL OF AFFECTIVE DISORDERS
Volume 251, Issue -, Pages 248-255

Publisher

ELSEVIER
DOI: 10.1016/j.jad.2019.03.069

Keywords

Suicide; Sleep; Depression; Anxiety; Inpatient; Psychiatry

Funding

  1. Menninger Clinic Foundation
  2. Robert and Janice McNair Foundation
  3. Vivian L. Smith Foundation
  4. Robert J. Kleberg, Jr. & Helen C. Kleberg Foundation
  5. Ray C. Fish Foundation
  6. Gordon A. Cain Foundation
  7. Huffington Foundation

Ask authors/readers for more resources

Background: As there has been a demonstrated link between sleep disturbance and suicide, the present study investigated the relationship between self-reported sleep disturbance during inpatient psychiatric treatment and clinical outcomes at discharge and six months post-discharge. Methods: Participants were 2,970 adults receiving care in a long-term inpatient psychiatric hospital. Greater than 90% of inpatients reported at least mild sleep disturbance throughout treatment. Group-based trajectory modeling was used to determine patterns of sleep disturbance changes over time. Results: Participants fit into distinct categories based on their trajectories of sleep problems across treatment: No Sleep Problems (10.3% of participants, no sleep problems endorsed over the course of inpatient psychiatric treatment), Resolvers (sleep problems completely resolved over the course of inpatient psychiatric treatment; 10.6%), Non-Responders (did not respond to inpatient psychiatric treatment; 35.7%) and Responders (sleep problems decreased but did not fully resolve over the course of inpatient psychiatric treatment; 43.4%). Individuals with comorbid major depressive disorder and generalized anxiety disorder were significantly more likely to demonstrate higher rates of sleep disturbance throughout inpatient psychiatric treatment and their sleep problems did not respond to treatment as usual (Non-Responders). Further, patients in the Non-Responder group had significantly more suicidal ideation and worse clinical outcomes (higher anxiety, more disability, and lower well-being) at discharge and six months post-discharge, as well as were on more medication including hypnotics throughout treatment. Conclusions: Findings indicate the urgent need to design and implement inpatient psychiatry sleep protocols to not only improve sleep and clinical outcomes, but also reduce the risk for suicide post-discharge.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Biochemistry & Molecular Biology

Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)

Maurizio Fava, Marlene P. Freeman, Martina Flynn, Heidi Judge, Bettina B. Hoeppner, Cristina Cusin, Dawn F. Ionescu, Sanjay J. Mathew, Lee C. Chang, Dan V. Iosifescu, James Murrough, Charles Debattista, Alan F. Schatzberg, Madhukar H. Trivedi, Manish K. Jha, Gerard Sanacora, Samuel T. Wilkinson, George I. Papakostas

MOLECULAR PSYCHIATRY (2020)

Correction Biochemistry & Molecular Biology

Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD) (vol 25, pg 1592, 2020)

Maurizio Fava, Marlene P. Freeman, Martina Flynn, Heidi Judge, Bettina B. Hoeppner, Cristina Cusin, Dawn F. Ionescu, Sanjay J. Mathew, Lee C. Chang, Dan V. Iosifescu, James Murrough, Charles Debattista, Alan F. Schatzberg, Madhukar H. Trivedi, Manish K. Jha, Gerard Sanacora, Samuel T. Wilkinson, George I. Papakostas

MOLECULAR PSYCHIATRY (2020)

Letter Clinical Neurology

Q-15 checks and 1:1 observations: Exacerbating a problem we are trying to solve?

Afsoon Gazor, Sanjay J. Mathew, Michelle A. Patriquin

JOURNAL OF AFFECTIVE DISORDERS (2020)

Editorial Material Psychiatry

Ketamine Plus Motivational Enhancement Therapy: Leveraging a Rapid Effect to Promote Enduring Change

Sanjay J. Mathew, Rebecca B. Price

AMERICAN JOURNAL OF PSYCHIATRY (2020)

Article Clinical Neurology

Time to relapse after a single administration of intravenous ketamine augmentation in unipolar treatment-resistant depression

Naji C. Salloum, Maurizio Fava, Rebecca S. Hock, Marlene P. Freeman, Martina Flynn, Bettina Hoeppner, Cristina Cusin, Dan V. Iosifescu, Madhukar H. Trivedi, Gerard Sanacora, Sanjay J. Mathew, Charles Debattista, Dawn F. Ionescu, George I. Papakostas

JOURNAL OF AFFECTIVE DISORDERS (2020)

Article Biochemistry & Molecular Biology

A randomized proof-of-mechanism trial applying the 'fast-fail' approach to evaluating κ-opioid antagonism as a treatment for anhedonia

Andrew D. Krystal, Diego A. Pizzagalli, Moria Smoski, Sanjay J. Mathew, John Nurnberger, Sarah H. Lisanby, Dan Iosifescu, James W. Murrough, Hongqiu Yang, Richard D. Weiner, Joseph R. Calabrese, Gerard Sanacora, Gretchen Hermes, Richard S. E. Keefe, Allen Song, Wayne Goodman, Steven T. Szabo, Alexis E. Whitton, Keming Gao, William Z. Potter

NATURE MEDICINE (2020)

Review Clinical Neurology

Objective measurement of sleep, heart rate, heart rate variability, and physical activity in suicidality: A systematic review

Gu Eon Kang, Michelle A. Patriquin, Hung Nguyen, Hyuntaek Oh, Katrina A. Rufino, Eric A. Storch, Bella Schanzer, Sanjay J. Mathew, Ramiro Salas, Bijan Najafi

JOURNAL OF AFFECTIVE DISORDERS (2020)

Article Neurosciences

Selective kappa-opioid antagonism ameliorates anhedonic behavior: evidence from the Fast-fail Trial in Mood and Anxiety Spectrum Disorders (FAST-MAS)

Diego A. Pizzagalli, Moria Smoski, Yuen-Siang Ang, Alexis E. Whitton, Gerard Sanacora, Sanjay J. Mathew, John Nurnberger, Sarah H. Lisanby, Dan Iosifescu, James W. Murrough, Hongqiu Yang, Richard D. Weiner, Joseph R. Calabrese, Wayne Goodman, William Z. Potter, Andrew D. Krystal

NEUROPSYCHOPHARMACOLOGY (2020)

Article Neurosciences

A randomized cross-over trial to define neurophysiological correlates of AV-101 N-methyl-d-aspartate receptor blockade in healthy veterans

Nicholas Murphy, Nithya Ramakrishnan, Bylinda Vo-Le, Brittany Vo-Le, Mark A. Smith, Tabish Iqbal, Alan C. Swann, Sanjay J. Mathew, Marijn Lijffijt

Summary: The kynurenine pathway is a promising target for treatment of depression and suicidality; AV-101, a modulator of this pathway, has potential as an antidepressant by targeting glutamate; A study found that 1440 mg of AV-101 can effectively engage with NMDAR in humans and is safe and well tolerated.

NEUROPSYCHOPHARMACOLOGY (2021)

Correction Neurosciences

Selective kappa-opioid antagonism ameliorates anhedonic behavior: evidence from the Fast-fail Trial in Mood and Anxiety Spectrum Disorders (FAST-MAS) (Aug, 10.1038/s41386-021-01145-9, 2021)

Diego A. Pizzagalli, Moria Smoski, Yuen-Siang Ang, Alexis E. Whitton, Gerard Sanacora, Sanjay J. Mathew, John Nurnberger, Sarah H. Lisanby, Dan V. Iosifescu, James W. Murrough, Hongqiu Yang, Richard D. Weiner, Joseph R. Calabrese, Wayne Goodman, William Z. Potter, Andrew D. Krystal

NEUROPSYCHOPHARMACOLOGY (2021)

Article Clinical Neurology

A Participant-Level Integrative Data Analysis of Differential Placebo Response for Suicidal Ideation and Nonsuicidal Depressive Symptoms in Clinical Trials of Intravenous Racemic Ketamine

Bartholt Bloomfield-Clagett, Elizabeth D. Ballard, Deanna K. Greenstein, Samuel T. Wilkinson, Michael F. Grunebaum, James W. Murrough, Sanjay J. Mathew, Jennifer L. Phillips, Maurizio Fava, Gerard Sanacora, Carlos A. Zarate

Summary: This study investigates the differential placebo response for suicidal ideation compared to other depressive symptoms in clinical trials of IV ketamine. The findings suggest that placebo response for suicidal ideation may be different from other symptoms, which may explain the less prominent effect of IV ketamine on suicidal ideation compared to overall depression.

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2022)

Article Neurosciences

Efficacy and safety of zuranolone co-initiated with an antidepressant in adults with major depressive disorder: results from the phase 3 CORAL study

Sagar V. Parikh, Scott T. Aaronson, Sanjay J. Mathew, Gustavo Alva, Charles Debattista, Stephen Kanes, Robert Lasser, Amy Bullock, Mona Kotecha, Jungah Jung, Fiona Forrestal, Jeff Jonas, Theresa Vera, Bridgette Leclair, James Doherty

Summary: Major depressive disorder (MDD) is a debilitating mental health disorder that can be difficult to treat with standard therapies. A study found that zuranolone+ADT led to faster improvement in depressive symptoms compared to placebo+ADT in MDD patients, with a good safety profile.

NEUROPSYCHOPHARMACOLOGY (2023)

Meeting Abstract Neurosciences

Cortical Gamma as a Marker of Kynurenine Pathway Engagement in Healthy Veterans Receiving L-4-Chloro-Kynurenine (AV-101)

Nicholas Murphy, Nithya Ramakrishnan, Bylinda Vo-Le, Brittany Vo-Le, Mark A. Smith, Tabish Iqbal, Alan C. Swann, Sanjay Mathew, Marijn Lijffijt

BIOLOGICAL PSYCHIATRY (2020)

Article Pharmacology & Pharmacy

Body Mass Index as a Moderator of Treatment Response to Ketamine for Major Depressive Disorder

Marlene P. Freeman, Rebecca S. Hock, George Papakostas, Heidi Judge, Cristina Cusin, Sanjay J. Mathew, Gerard Sanacora, Dan Iosifescu, Charles DeBattista, Madhukar H. Trivedi, Maurizio Fava

JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2020)

Article Psychiatry

Psychotherapy for Mixed Depression and Mixed Mania

Brittany O'Brien, Delphine Lee, Alan C. Swann, Sanjay J. Mathew, Marijn Lijffijt

PSYCHIATRIC CLINICS OF NORTH AMERICA (2020)

Article Clinical Neurology

Characterizing depression after traumatic brain injury using a symptom-oriented approach

Jai Carmichael, Jennie Ponsford, Kate Rachel Gould, Gershon Spitz

Summary: The traditional approaches to measuring depression after traumatic brain injury (TBI) have limitations. This study adopted a symptom-oriented approach and found that post-TBI depression is highly heterogeneous. Different depressive symptoms have distinct associations with personal, injury-related, treatment, and outcome factors.

JOURNAL OF AFFECTIVE DISORDERS (2024)

Letter Clinical Neurology

Response to Słupski & Słupska

Josine E. Verhoeven, Laura K. M. Han, Brenda W. J. H. Penninx

JOURNAL OF AFFECTIVE DISORDERS (2024)

Review Clinical Neurology

The association between trichotillomania symptoms and emotion regulation difficulties: A systematic review and meta-analysis

Erin Crowe, Petra K. Staiger, Steven J. Bowe, Imogen Rehm, Richard Moulding, Caitlyn Herrick, David J. Hallford

Summary: This study aimed to integrate the evidence regarding the relationship between emotion regulation difficulties and TTM symptoms, and found that individuals with higher levels of TTM severity appear to exhibit decreased overall emotion regulation abilities and strategies.

JOURNAL OF AFFECTIVE DISORDERS (2024)

Letter Clinical Neurology

'The association between gut-health promoting diet and depression: A mediation analysis'

Fjolla Berisha, Marjolaine Rivest-Beauregard, Jai Shah, Michelle Lonergan, Alain Brunet

JOURNAL OF AFFECTIVE DISORDERS (2024)

Article Clinical Neurology

The impact of sleep disturbances on suicide risk among people living HIV: An eleven-year national cohort

Yi-Tseng Tsai, Tzu-Jung Chuang, Sriyani Padmalatha Konara Mudiyanselage, Han-Chang Ku, Yi-Lin Wu, Chung-Yi Li, Nai-Ying Ko

Summary: Sleep disturbances are associated with higher suicide rates, and this association is independent of depression. Paying attention to sleep disturbances among PLHIV is crucial when monitoring suicidal ideation.

JOURNAL OF AFFECTIVE DISORDERS (2024)

Article Clinical Neurology

Patterns in suicide by marital status in Hong Kong, 2002-2020: Is marriage still a protective factor against suicide?

Junyou Chen, Ingrid D. Lui, Yu Cheng Hsu, Paul S. F. Yip

Summary: Despite rapid social changes in Hong Kong, marriage remains a strong protective factor against suicide for both men and women, particularly among younger individuals. Increasing suicide rates among divorced/separated, never-married, or widowed individuals suggest a need for more psychosocial support.

JOURNAL OF AFFECTIVE DISORDERS (2024)

Article Clinical Neurology

Perinatal sleep disruption and postpartum psychosis in bipolar disorder: Findings from the UK BDRN Pregnancy Study

A. Perry, K. Gordon-Smith, K. J. S. Lewis, A. Di Florio, N. Craddock, L. Jones, I. Jones

Summary: This study found that the experience of losing at least one night of sleep was associated with an increased risk of postpartum psychosis in women with bipolar disorder. Sleep quality in late pregnancy was not associated with postpartum psychosis, and perinatal sleep disruption was not associated with postpartum depression.

JOURNAL OF AFFECTIVE DISORDERS (2024)

Letter Clinical Neurology

National Network of Depression Centers position statement: Insurance coverage for intravenous ketamine in treatment-resistant major depressive disorder

Dear J. Affect Disord, Mark J. Niciu, Robert C. Meisner, Brent R. Carr, Ali A. Farooqui, David Feifel, Adam Kaplin, Paul M. Kim, Christopher D. Schneck, Jennifer L. Vande Voort, Sagar Parikh, E. Jeremy Kendrick

JOURNAL OF AFFECTIVE DISORDERS (2024)

Article Clinical Neurology

The relationship between psychological pain and suicidality in patients with major depressive disorder: A meta-analysis

Tao Wang, Li Yang, Lan Yang, Bao-Peng Liu, Cun-Xian Jia

Summary: This study systematically reviewed the association between psychological pain and suicidality in patients with major depressive disorder (MDD). The results showed that psychological pain was a risk factor for suicidality in MDD patients, especially for those of advancing age. Reducing psychological pain in MDD patients is important for preventing suicidality.

JOURNAL OF AFFECTIVE DISORDERS (2024)

Letter Clinical Neurology

Spilling the tea about milk tea addiction - A reply to Qu et al. (2023)

Juan Carlos Hugues, Abel Nogueira-Lopeza, Maeva Flayellea, Cora von Hammersteind, Joel Billieuxa

JOURNAL OF AFFECTIVE DISORDERS (2024)

Article Clinical Neurology

The role of family accommodation in child posttraumatic stress symptoms and functional impairment in the context of cognitive behavioral therapy

Ogechi Cynthia Onyeka, Samuel D. Spencer, Alison Salloum, Katie Jiannetto, Eric A. Storch

Summary: This study examined the relationship among family accommodation (FA), posttraumatic stress symptoms (PTSS), and functional impairment. The results showed that FA was significantly associated with PTSS and functional impairment. Baseline FA partially mediated the relationship between baseline PTSS and functional impairment. Changes in FA from pre- to post-treatment were associated with relevant outcome variables at post-treatment and 12-month follow-up.

JOURNAL OF AFFECTIVE DISORDERS (2024)

Article Clinical Neurology

Effect of dietary living microbe intake on depression symptom in American adult: An opinion from NHANES study

Yumeng Shi, Chao Yu

Summary: This study found a negative correlation between the intake of active microbes in the diet and depression.

JOURNAL OF AFFECTIVE DISORDERS (2024)

Article Clinical Neurology

Analysis of sleep for the American population: Result from NHANES database

Qiurui Nie, Yu Shen, Mengqin Luo, Zhiyong Sheng, Rui Zhou, Guangmin Li, Wei Huang, Shenjian Chen

Summary: The study assessed the sleep duration, sleep disorders, and trouble sleeping among adults in the United States from 2005 to 2018, revealing a high prevalence of abnormal sleep durations and increasing rates of sleep disorders and trouble sleeping.

JOURNAL OF AFFECTIVE DISORDERS (2024)